DrugPatentWatch Archives

You are currently viewing the 2001 archives
Click here to return to the current data set

Search for Tradename: teveten

Summary for Tradename: teveten

Patents:	2
Applicants:	1
NDAs:	2
Therapeutic Class:	Cardiovascular Agents

Glossary

Applicant	Tradename	Generic Name	NDA	Approval Date	Type	RLD	Patent Number	Patent Expiration	Exclusivity Expiration
Unimed Pharms	TEVETEN	eprosartan mesylate	020738	DEC 22, 1997	RX	No			DEC 22,2002
Unimed Pharms	TEVETEN	eprosartan mesylate	020738	DEC 22, 1997	RX	No			OCT 28,2001
Unimed Pharms	TEVETEN	eprosartan mesylate	020738	DEC 22, 1997	RX	No	5,185,351	FEB 09,2010

Export available with Ultimate Plan subscription:

This preview shows a limited data set. Complete access is available with a Subscription

Paragraph IV activity for: TEVETEN

Drugname	Dosage	Strength	RLD	Submissiondate
eprosartan mesylate	Tablets	400 mg and 600 mg	Teveten	5/10/2010

<- Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Follow DrugPatentWatch on Twitter

Bookmark or Share This Page ...